TechnoPhage
PrivateLast Round
Grant
Jul 25, 2022
Total Funding Raised
$5.6M
Momentum Score
25 /100
Company Overview
TechnoPhage is a biotechnology and drug discovery company that develops innovative therapies for unmet medical needs in infection, neurosciences, and ophthalmology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TechnoPhage Comps
Public and private peers based on sector, stage, and business model.
TechnoPhage Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 25, 2022 | ||||
| Accelerator | Jan 1, 2020 | ||||
| Grant | Feb 1, 2015 |
Key People
Founding team and executive leadership
TechnoPhage Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Commission | Grant |
| Portuguese Government | Grant |
| Johnson & Johnson Innovation - JLABS | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 21, 2026
Grew 15% QoQ from 26 to 30 employees.
- Jun 7, 2025
Grew 22% QoQ, from 27 to 33 employees.
TechnoPhage Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TechnoPhage's valuation, stock price, and market status.
